|
1
|
Wood RD, Mitchell M, Sgouros J and Lindahl
T: Human DNA repair genes. Science. 291:1284–1289. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
De Silva IU, McHugh PJ, Clingen PH and
Hartley JA: Defining the roles of nucleotide excision repair and
recombination in the repair of DNA interstrand cross-links in
mammalian cells. Mol Cell Biol. 20:7980–7990. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen ZP, Malapetsa A, McQuillan A, et al:
Evidence for nucleotide excision repair as a modifying factor of
O6-methylguanine-DNA methyltransferase-mediated innate
chloroethylnitrosourea resistance in human tumor cell lines. Mol
Pharmacol. 52:815–820. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Goode EL, Ulrich CM and Potter JD:
Polymorphisms in DNA repair genes and associations with cancer
risk. Cancer Epidemiol Biomarkers Prev. 11:1513–1530.
2002.PubMed/NCBI
|
|
5
|
Fontana L, Bosviel R, Delort L, et al: DNA
repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations
with bladder cancer risk in a french cohort. Anticancer Res.
28:1853–1856. 2008.PubMed/NCBI
|
|
6
|
Huang MY, Fang WY, Lee SC, Cheng TL, Wang
JY and Lin SR: ERCC2 2251A>C genetic polymorphism was highly
correlated with early relapse in high-risk stage II and stage III
colorectal cancer patients: a preliminary study. BMC Cancer.
8:502008. View Article : Google Scholar :
|
|
7
|
Li J, Jin W, Chen Y, Di G, Wu J and Shao
ZM: Genetic polymorphisms in the DNA repair enzyme ERCC2 and breast
tumour risk in a Chinese population. J Int Med Res. 36:479–488.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bernard-Gallon D, Bosviel R, Delort L, et
al: DNA repair gene ERCC2 polymorphisms and associations with
breast and ovarian cancer risk. Mol Cancer. 7:362008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yao L, Qiu LX, Yu L, et al: The
association between ERCC2 Asp312Asn polymorphism and breast cancer
risk: a meta-analysis involving 22,766 subjects. Breast Cancer Res
Treat. 123:227–231. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang Z, Fang X, Pei X and Li H:
Polymorphisms in the ERCC1 and XPF genes and risk of breast cancer
in a Chinese population. Genet Test Mol Biomarkers. 17:700–706.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tan X, Wang Y, Shi L, et al: Polymorphism
of ERCC2 Asp312Asn with lung cancer risk: evidence from 20,101
subjects. Genet Test Mol Biomarkers. 18:50–56. 2014. View Article : Google Scholar
|
|
12
|
Wen F, Zhao Z, Liu C, et al: A pooled
analysis of the ERCC2 Asp312Asn polymorphism and esophageal cancer
susceptibility. Tumour Biol. 35:2959–2965. 2014. View Article : Google Scholar
|
|
13
|
Deng Q, Sheng L, Su D, et al: Genetic
polymorphisms in ATM, ERCC1, APE1 and iASPP genes and lung cancer
risk in a population of southeast china. Med Oncol. 28:667–672.
2011. View Article : Google Scholar
|
|
14
|
Lin H, Lin D and Zheng C: Association of
XPD Lys751Gln polymorphism with head and neck cancer
susceptibility: evidence from 11,443 subjects. Diagn Pathol.
9:152014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang L, Wang J, Xu L, et al: Nucleotide
excision repair gene ERCC1 polymorphisms contribute to cancer
susceptibility: a meta-analysis. Mutagenesis. 27:67–76. 2012.
View Article : Google Scholar
|
|
16
|
Gustincich S, Manfioletti G, Del Sal G,
Schneider C and Carninci P: A fast method for high-quality genomic
DNA extraction from whole human blood. Biotechniques. 11:298–300.
3021991.PubMed/NCBI
|
|
17
|
Yu JJ, Lee KB, Mu C, et al: Comparison of
two human ovarian carcinoma cell lines (A2780/CP70 and MCAS) that
are equally resistant to platinum, but differ at codon 118 of the
ERCC1 gene. Int J Oncol. 16:555–560. 2000.PubMed/NCBI
|
|
18
|
Lunn RM, Helzlsouer KJ, Parshad R, et al:
XPD polymorphisms: effects on DNA repair proficiency.
Carcinogenesis. 21:551–555. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Duell EJ, Wiencke JK, Cheng TJ, et al:
Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and
biomarkers of DNA damage in human blood mononuclear cells.
Carcinogenesis. 21:965–971. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lichtenstein P, Holm NV, Verkasalo PK, et
al: Environmental and heritable factors in the causation of cancer
- analyses of cohorts of twins from Sweden, Denmark, and Finland. N
Engl J Med. 343:78–85. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yin M, Yan J, Martinez-Balibrea E, et al:
ERCC1 and ERCC2 polymorphisms predict clinical outcomes of
oxaliplatin-based chemotherapies in gastric and colorectal cancer:
a systemic review and meta-analysis. Clin Cancer Res. 17:1632–1640.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Adeyemo A and Rotimi C: Genetic variants
associated with complex human diseases show wide variation across
multiple populations. Public Health Genomics. 13:72–79. 2010.
View Article : Google Scholar :
|
|
23
|
Paszkowska-Szczur K, Scott RJ, Gorski B,
et al: Polymorphisms in nucleotide excision repair genes and
susceptibility to colorectal cancer in the Polish population. Mol
Biol Rep. 2014.PubMed/NCBI
|
|
24
|
Gao K, Mu SQ and Wu ZX: Investigation of
the effects of single-nucleotide polymorphisms in DNA repair genes
on the risk of glioma. Genet Mol Res. 13:1203–1211. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chu H, Gu D, Xu M, et al: A genetic
variant in ERCC2 is associated with gastric cancer prognosis in a
Chinese population. Mutagenesis. 28:441–446. 2013. View Article : Google Scholar : PubMed/NCBI
|
